Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

David H Ilson, MD, discusses thoughts on PEG IL-10 and PEGPH20 studies presented at ASCO GI

Dr. Ilson, Memorial Sloan Kettering Cancer Center, shares thoughts on the clinical trial results of PEG IL-10 and PEGPH20 studies in pancreas cancer presented at ASCO GI 2020

Tags: Pancreatic

Published: 31 January 2020

Recent Videos: Pancreatic

video

David H Ilson, MD, discusses thoughts on PEG IL-10 and PEGPH20 studies presented at ASCO GI

Dr. Ilson, Memorial Sloan Kettering Cancer Center, shares thoughts on the clinical trial results of PEG IL-10 and PEGPH20 studies ...

video

Eileen O'Reilly, MD, shares outcomes of the POLO study and its importance to physicians

Dr. O'Reilly, Winthrop Rockefeller Endowed Chair in Medical Oncology, Memorial Sloan Kettering Cancer Center, shares outcomes of the POLO study ...

video

Eileen O'Reilly, MD, describes how physicians should test for BRCA in pancreatic cancer patients

Dr. O'Reilly, Winthrop Rockefeller Endowed Chair in Medial Oncology, Memorial Sloan Kettering Cancer Center, shares opinion on how physicians should ...

video

Irvin Modlin, MD, on when to use NETest clinically and situations it has clinical utility

Dr. Modlin, Professor Emeritus, Yale School of Medicine, elaborates on when to NETest clinically and situations in which it has ...

video

Philip Philip, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

Dr. Philip, Clinical Professor of Oncology, Wayne State University of Medicine, shares perspective on the phase 2 study comparing gemcitabine/cisplatin ...

video

Philip Philip, MD, shares opinion on treatment of a BRCA+ pancreatic cancer patient

Dr. Philip, Clinical Professor of Oncology, Wayne State University of Medicine, shares opinion regarding his typical treatment of BRCA+ pancreatic ...

video

Philip Philip, MD, explains how physicians should test for BRCA in pancreatic cancer patients

Dr. Philip, Clinical Professor of Oncology, Wayne State University of Medicine, provides opinion on how physicians should test for BRCA ...

video

Philip Philip, MD, on the outcomes of the POLO study and its importance to physicians

Dr. Philip, Clinical Professor of Oncology, Wayne State University of Medicine, elaborates on the outcomes of the POLO study and ...

video

Philip Philip, MD, provides thoughts on the role of PARP inhibitors in advanced pancreatic cancer

Dr. Philip, Professor of Oncology, Wayne State University of Medicine, provides thoughts regarding the role of PARP inhibitors in advanced ...

video

Eileen O'Reilly, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

Dr. O'Reilly, Winthrop Rockefeller Endowed Chair in Medical Oncology, Memorial Sloan Kettering Center, shares perspective on the phase 2 study ...

Related Videos

video-image

Eileen O'Reilly, MD, shares outcomes of the POLO study and its importance to physicians

video-image

Eileen O'Reilly, MD, describes how physicians should test for BRCA in pancreatic cancer patients

video-image

Irvin Modlin, MD, on when to use NETest clinically and situations it has clinical utility

video-image

Philip Philip, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

video-image

Philip Philip, MD, shares opinion on treatment of a BRCA+ pancreatic cancer patient

video-image

Philip Philip, MD, explains how physicians should test for BRCA in pancreatic cancer patients

video-image

Philip Philip, MD, on the outcomes of the POLO study and its importance to physicians

video-image

Philip Philip, MD, provides thoughts on the role of PARP inhibitors in advanced pancreatic cancer

video-image

Eileen O'Reilly, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

video-image

Eileen O'Reilly, MD, provides evidence to inform treatment of pancreatic cancer patients

video-image

Philip Philip MD, PhD, FRCP, on the APACT trial in surgically resected pancreatic adenocarcinoma

video-image

Vincent Chung, MD, shares details from the APACT study in pancreatic adenocarcinoma

video-image

Josep Tabernero, MD, PhD, provides perspective on the POLO trial in pancreatic

video-image

Philip Philip MD, PhD, FRCP, on BRCA gene mutations & outcomes in pancreatic cancer

video-image

Vincent Chung, MD, elaborates on BRCA mutations and pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, discusses outcomes from the POLO trial in pancreatic cancer

video-image

Vincent Chung, MD, shares outcomes from the POLO trial metastatic pancreatic cancer

video-image

Leonard Saltz, MD, shares outcomes from the APACT trial in pancreatic adenocarcinoma

video-image

Talia Golan, MD, explains the role of biomarkers in the treatment of pancreatic cancer

video-image

Talia Golan, MD, regarding the practice-changing potential of the POLO trial

video-image

Thomas A. Abrams, MD, elaborates on the outcomes from the APACT study

video-image

Talia Golan, MD, elaborates on the outcomes from the POLO study presented at ASCO 2019

video-image

Thomas A. Abrams, MD, provides perspective on the POLO trial in metastatic pancreatic cancer

video-image

John Strickler, MD, shares thoughts on molecular subtyping of pancreatic cancer

video-image

Zev Wainberg, MD, on checkpoint inhibition with chemotherapy in pancreatic cancer

video-image

Bassel El-Reyes, MD, speculates on promising novel therapies being developed for pancreatic cancer

video-image

Bassel El-Reyes, MD, considers upfront surgery for resectable pancreatic cancer

video-image

Bassel El-Reyes, MD, offers his opinion on NGS & BRCA gene testing for pancreatic cancer

video-image

Bassel El-Reyes, MD, regarding molecular subtyping of pancreatic cancer

video-image

Rachna Shroff, MD, gives her take on pre-operative therapy in resectable pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, on promising novel therapies for pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, provides opinion on NGS and BRCA gene testing in pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, considers molecular subtyping of pancreatic cancer

video-image

Philip Philip MD, PhD, FRCP, on screening patients at high risk for pancreatic cancer

video-image

John Leighton, MD, regarding preoperative chemotherapy in resectable pancreatic cancer

video-image

John Leighton, MD, regarding the PA.6 clinical study presented at ASCO 2018

video-image

James A. Posey III, MD, on the outcomes of the LAPACT study in locally advanced pancreatic cancer

video-image

James A. Posey III, MD, comments on the impact of immunotherapy agents in pancreatic cancer

video-image

James A. Posey III, MD, discusses the unmet medical needs in pancreatic ductal adenocarcinoma

video-image

James A. Posey III, MD, offers opinion on preoperative chemotherapy in resectable pancreatic cancer

video-image

James A. Posey III, MD, on the results and implications of the PA.6 clinical trial from ASCO 2018

video-image

Richard Goldberg, MD, on how the FIRE-3 data in CRC presented at ASCO 2018 reinforces CALGB 80405

video-image

Richard Goldberg, MD, considers the value of preoperative chemotherapy in pancreatic cancer

video-image

Richard Goldberg, MD, regarding the outcomes of the PA.6 clinical study in pancreatic cancer

video-image

Al Benson III, MD, FACP, tells us about the outcomes of the ECOG-ACRIN study

video-image

Philip Philip, MD, PhD, FRCP, on the implications of the LAPACT study presented at ASCO 2018

video-image

Philip Philip, MD, PhD, FRCP, considers the impact of immunotherapy agents in pancreatic cancer

video-image

Philip Philip, MD, PhD, FRCP, regarding key unmet needs in pancreatic ductal adenocarcinoma

video-image

Philip Philip, MD, reflects on the impact of PEGPH20 in met pancreatic cancer

video-image

Philip Philip, MD, talks about treating a newly diagnosed stage 4 pancreatic cancer patient

video-image

Philip Philip, MD, on whether resected pancreatic cancer patients should be offered adjuvant therapy

video-image

Richard M. Goldberg, MD, FASCO on adjuvant pancreatic cancer news

video-image

Pancreatic Cancer News from ASCO GI 2016